Global and China Arthritis Drug Market Insights, Forecast to 2026

Global and China Arthritis Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Arthritis Drug Product Introduction
1.2 Market Segments
1.3 Key Arthritis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Arthritis Drug Market Size Growth Rate by Type
1.4.2 Synthetic DMARDs
1.4.3 Biological DMARDs
1.4.4 NSAIDs
1.4.5 Corticosteroids
1.4.6 Analgesics
1.5 Market by Application
1.5.1 Global Arthritis Drug Market Size Growth Rate by Application
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Drug Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Arthritis Drug Market Size, Estimates and Forecasts
2.1.1 Global Arthritis Drug Revenue 2015-2026
2.1.2 Global Arthritis Drug Sales 2015-2026
2.2 Global Arthritis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Arthritis Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Arthritis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Arthritis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Arthritis Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Arthritis Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Arthritis Drug Revenue Forecast by Region (2021-2026)
3 Global Arthritis Drug Competitor Landscape by Players
3.1 Global Top Arthritis Drug Sales by Manufacturers
3.1.1 Global Arthritis Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Arthritis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Arthritis Drug Manufacturers by Revenue
3.2.1 Global Arthritis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Arthritis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Arthritis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Arthritis Drug Revenue in 2019
3.2.5 Global Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Arthritis Drug Price by Manufacturers
3.4 Global Arthritis Drug Manufacturing Base Distribution, Product Types
3.4.1 Arthritis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Arthritis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Arthritis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Arthritis Drug Market Size by Type (2015-2020)
4.1.1 Global Arthritis Drug Sales by Type (2015-2020)
4.1.2 Global Arthritis Drug Revenue by Type (2015-2020)
4.1.3 Arthritis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Arthritis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Arthritis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Arthritis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Arthritis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Arthritis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Arthritis Drug Market Size by Application (2015-2020)
5.1.1 Global Arthritis Drug Sales by Application (2015-2020)
5.1.2 Global Arthritis Drug Revenue by Application (2015-2020)
5.1.3 Arthritis Drug Price by Application (2015-2020)
5.2 Arthritis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Arthritis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Arthritis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Arthritis Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Arthritis Drug Market Size YoY Growth 2015-2026
6.1.1 China Arthritis Drug Sales YoY Growth 2015-2026
6.1.2 China Arthritis Drug Revenue YoY Growth 2015-2026
6.1.3 China Arthritis Drug Market Share in Global Market 2015-2026
6.2 China Arthritis Drug Market Size by Players (International and Local Players)
6.2.1 China Top Arthritis Drug Players by Sales (2015-2020)
6.2.2 China Top Arthritis Drug Players by Revenue (2015-2020)
6.3 China Arthritis Drug Historic Market Review by Type (2015-2020)
6.3.1 China Arthritis Drug Sales Market Share by Type (2015-2020)
6.3.2 China Arthritis Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Arthritis Drug Price by Type (2015-2020)
6.4 China Arthritis Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Arthritis Drug Sales Forecast by Type (2021-2026)
6.4.2 China Arthritis Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Arthritis Drug Price Forecast by Type (2021-2026)
6.5 China Arthritis Drug Historic Market Review by Application (2015-2020)
6.5.1 China Arthritis Drug Sales Market Share by Application (2015-2020)
6.5.2 China Arthritis Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Arthritis Drug Price by Application (2015-2020)
6.6 China Arthritis Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Arthritis Drug Sales Forecast by Application (2021-2026)
6.6.2 China Arthritis Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Arthritis Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Arthritis Drug Market Size YoY Growth 2015-2026
7.2 North America Arthritis Drug Market Facts & Figures by Country
7.2.1 North America Arthritis Drug Sales by Country (2015-2020)
7.2.2 North America Arthritis Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Arthritis Drug Market Size YoY Growth 2015-2026
8.2 Europe Arthritis Drug Market Facts & Figures by Country
8.2.1 Europe Arthritis Drug Sales by Country
8.2.2 Europe Arthritis Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Arthritis Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Arthritis Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Arthritis Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Arthritis Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Arthritis Drug Market Size YoY Growth 2015-2026
10.2 Latin America Arthritis Drug Market Facts & Figures by Country
10.2.1 Latin America Arthritis Drug Sales by Country
10.2.2 Latin America Arthritis Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Arthritis Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Arthritis Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Arthritis Drug Sales by Country
11.2.2 Middle East and Africa Arthritis Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Arthritis Drug Products Offered
12.1.5 Novartis Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Description and Business Overview
12.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly Arthritis Drug Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Celltrion
12.3.1 Celltrion Corporation Information
12.3.2 Celltrion Description and Business Overview
12.3.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celltrion Arthritis Drug Products Offered
12.3.5 Celltrion Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Corporation Information
12.4.2 F. Hoffmann-La Roche Description and Business Overview
12.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
12.4.4 F. Hoffmann-La Roche Arthritis Drug Products Offered
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Arthritis Drug Products Offered
12.5.5 Pfizer Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Arthritis Drug Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 GSK
12.7.1 GSK Corporation Information
12.7.2 GSK Description and Business Overview
12.7.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GSK Arthritis Drug Products Offered
12.7.5 GSK Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novartis Arthritis Drug Products Offered
12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Arthritis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Arthritis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Arthritis Drug Market Segments
Table 2. Ranking of Global Top Arthritis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Arthritis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Synthetic DMARDs
Table 5. Major Manufacturers of Biological DMARDs
Table 6. Major Manufacturers of NSAIDs
Table 7. Major Manufacturers of Corticosteroids
Table 8. Major Manufacturers of Analgesics
Table 9. Global Arthritis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Arthritis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Arthritis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Arthritis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Arthritis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Arthritis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Arthritis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Arthritis Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Arthritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arthritis Drug as of 2019)
Table 19. Arthritis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Arthritis Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Arthritis Drug Price (2015-2020) (USD/Pcs)
Table 22. Arthritis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Arthritis Drug Product Type
Table 24. Date of International Manufacturers Enter into Arthritis Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Arthritis Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Arthritis Drug Sales Share by Type (2015-2020)
Table 28. Global Arthritis Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Arthritis Drug Revenue Share by Type (2015-2020)
Table 30. Arthritis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Arthritis Drug Sales Share by Type (2021-2026)
Table 32. Global Arthritis Drug Sales by Application (2015-2020) (K Pcs)
Table 33. Global Arthritis Drug Sales Share by Application (2015-2020)
Table 34. Global Arthritis Drug Sales Share by Application (2021-2026)
Table 35. Global Arthritis Drug Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Arthritis Drug Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Arthritis Drug Revenue Market Share Forecast by Application (2021-2026)
Table 38. China Arthritis Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 39. China Arthritis Drug Sales Share by Company (2015-2020)
Table 40. China Arthritis Drug Revenue (US$ Million) by Company (2015-2020)
Table 41. China Arthritis Drug Sales (K Pcs) by Type (2015-2020)
Table 42. China Arthritis Drug Sales Share by Type (2015-2020)
Table 43. China Arthritis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. China Arthritis Drug Price (K Pcs) by Type (2015-2020)
Table 45. China Arthritis Drug Sales (K Pcs) by Type (2021-2026)
Table 46. China Arthritis Drug Sales Share by Type (2021-2026)
Table 47. China Arthritis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. China Arthritis Drug Revenue Share by Type (2021-2026)
Table 49. China Arthritis Drug Price (K Pcs) by Type (2021-2026)
Table 50. China Arthritis Drug Sales (K Pcs) by Application (2015-2020)
Table 51. China Arthritis Drug Sales Share by Application (2015-2020)
Table 52. China Arthritis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. China Arthritis Drug Sales (K Pcs) by Application (2021-2026)
Table 54. China Arthritis Drug Sales Share by Application (2021-2026)
Table 55. China Arthritis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. China Arthritis Drug Revenue Share by Application (2021-2026)
Table 57. North America Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 58. North America Arthritis Drug Sales Market Share by Country (2015-2020)
Table 59. North America Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 61. Europe Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Arthritis Drug Sales Market Share by Country (2015-2020)
Table 63. Europe Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Arthritis Drug Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Arthritis Drug Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Arthritis Drug Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Arthritis Drug Revenue Market Share by Region (2015-2020)
Table 69. Latin America Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Arthritis Drug Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Arthritis Drug Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Arthritis Drug Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Arthritis Drug Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Arthritis Drug Revenue Market Share by Country (2015-2020)
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Arthritis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Novartis Arthritis Drug Product
Table 81. Novartis Recent Development
Table 82. Eli Lilly Corporation Information
Table 83. Eli Lilly Description and Business Overview
Table 84. Eli Lilly Arthritis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Eli Lilly Product
Table 86. Eli Lilly Recent Development
Table 87. Celltrion Corporation Information
Table 88. Celltrion Description and Business Overview
Table 89. Celltrion Arthritis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Celltrion Product
Table 91. Celltrion Recent Development
Table 92. F. Hoffmann-La Roche Corporation Information
Table 93. F. Hoffmann-La Roche Description and Business Overview
Table 94. F. Hoffmann-La Roche Arthritis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. F. Hoffmann-La Roche Product
Table 96. F. Hoffmann-La Roche Recent Development
Table 97. Pfizer Corporation Information
Table 98. Pfizer Description and Business Overview
Table 99. Pfizer Arthritis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Pfizer Product
Table 101. Pfizer Recent Development
Table 102. Johnson & Johnson Corporation Information
Table 103. Johnson & Johnson Description and Business Overview
Table 104. Johnson & Johnson Arthritis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Johnson & Johnson Product
Table 106. Johnson & Johnson Recent Development
Table 107. GSK Corporation Information
Table 108. GSK Description and Business Overview
Table 109. GSK Arthritis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. GSK Product
Table 111. GSK Recent Development
Table 112. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 113. Key Challenges
Table 114. Market Risks
Table 115. Main Points Interviewed from Key Arthritis Drug Players
Table 116. Arthritis Drug Customers List
Table 117. Arthritis Drug Distributors List
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Arthritis Drug Product Picture
Figure 2. Global Arthritis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Synthetic DMARDs Product Picture
Figure 4. Biological DMARDs Product Picture
Figure 5. NSAIDs Product Picture
Figure 6. Corticosteroids Product Picture
Figure 7. Analgesics Product Picture
Figure 8. Global Arthritis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Retail Pharmacies
Figure 10. Hospital Pharmacies
Figure 11. Drug Stores
Figure 12. E-Commerce
Figure 13. Arthritis Drug Report Years Considered
Figure 14. Global Arthritis Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Arthritis Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Arthritis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Arthritis Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Arthritis Drug Sales Market Share by Region in 2019
Figure 19. Global Arthritis Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Arthritis Drug Revenue Market Share by Region in 2019
Figure 21. Global Arthritis Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Arthritis Drug Revenue in 2019
Figure 23. Arthritis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Arthritis Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Arthritis Drug Sales Market Share by Type in 2019
Figure 26. Global Arthritis Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Arthritis Drug Revenue Market Share by Type in 2019
Figure 28. Global Arthritis Drug Market Share by Price Range (2015-2020)
Figure 29. Global Arthritis Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Arthritis Drug Sales Market Share by Application in 2019
Figure 31. Global Arthritis Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Arthritis Drug Revenue Market Share by Application in 2019
Figure 33. China Arthritis Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. China Arthritis Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. China Arthritis Drug Market Share in Global Market 2015-2026
Figure 36. China 5 and 10 Largest Arthritis Drug Players Market Share by Revenue in Arthritis Drug in 2019
Figure 37. China Arthritis Drug Revenue Share by Type (2015-2020)
Figure 38. China Arthritis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 39. China Arthritis Drug Revenue Share by Application (2015-2020)
Figure 40. China Arthritis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Arthritis Drug Sales Market Share by Country in 2019
Figure 44. North America Arthritis Drug Revenue Market Share by Country in 2019
Figure 45. U.S. Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Arthritis Drug Sales Market Share by Country in 2019
Figure 52. Europe Arthritis Drug Revenue Market Share by Country in 2019
Figure 53. Germany Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Arthritis Drug Sales Market Share by Region in 2019
Figure 66. Asia Pacific Arthritis Drug Revenue Market Share by Region in 2019
Figure 67. China Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Arthritis Drug Sales Market Share by Country in 2019
Figure 92. Latin America Arthritis Drug Revenue Market Share by Country in 2019
Figure 93. Mexico Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Arthritis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Arthritis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Arthritis Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Arthritis Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Arthritis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Arthritis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. Arthritis Drug Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs